Lowe syndrome

<p>Abstract</p> <p>Lowe syndrome (the oculocerebrorenal syndrome of Lowe, OCRL) is a multisystem disorder characterised by anomalies affecting the eye, the nervous system and the kidney. It is a uncommon, panethnic, X-linked disease, with estimated prevalence in the general populat...

Full description

Bibliographic Details
Main Author: Loi Mario
Format: Article
Language:English
Published: BMC 2006-05-01
Series:Orphanet Journal of Rare Diseases
Online Access:http://www.OJRD.com/content/1/1/16
_version_ 1818229220148510720
author Loi Mario
author_facet Loi Mario
author_sort Loi Mario
collection DOAJ
description <p>Abstract</p> <p>Lowe syndrome (the oculocerebrorenal syndrome of Lowe, OCRL) is a multisystem disorder characterised by anomalies affecting the eye, the nervous system and the kidney. It is a uncommon, panethnic, X-linked disease, with estimated prevalence in the general population of approximately 1 in 500,000. Bilateral cataract and severe hypotonia are present at birth. In the subsequent weeks or months, a proximal renal tubulopathy (Fanconi-type) becomes evident and the ocular picture may be complicated by glaucoma and cheloids. Psychomotor retardation is evident in childhood, while behavioural problems prevail and renal complications arise in adolescence. The mutation of the gene <it>OCRL1 </it>localized at Xq26.1, coding for the enzyme phosphatidylinositol (4,5) bisphosphate 5 phosphatase, PtdIns (4,5)P2, in the trans-Golgi network is responsible for the disease. Both enzymatic and molecular testing are available for confirmation of the diagnosis and for prenatal detection of the disease. The treatment includes: cataract extraction, glaucoma control, physical and speech therapy, use of drugs to address behavioural problems, and correction of the tubular acidosis and the bone disease with the use of bicarbonate, phosphate, potassium and water. Life span rarely exceeds 40 years.</p>
first_indexed 2024-12-12T10:15:08Z
format Article
id doaj.art-ca1283beaeb44896a079f0e910d59469
institution Directory Open Access Journal
issn 1750-1172
language English
last_indexed 2024-12-12T10:15:08Z
publishDate 2006-05-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj.art-ca1283beaeb44896a079f0e910d594692022-12-22T00:27:41ZengBMCOrphanet Journal of Rare Diseases1750-11722006-05-01111610.1186/1750-1172-1-16Lowe syndromeLoi Mario<p>Abstract</p> <p>Lowe syndrome (the oculocerebrorenal syndrome of Lowe, OCRL) is a multisystem disorder characterised by anomalies affecting the eye, the nervous system and the kidney. It is a uncommon, panethnic, X-linked disease, with estimated prevalence in the general population of approximately 1 in 500,000. Bilateral cataract and severe hypotonia are present at birth. In the subsequent weeks or months, a proximal renal tubulopathy (Fanconi-type) becomes evident and the ocular picture may be complicated by glaucoma and cheloids. Psychomotor retardation is evident in childhood, while behavioural problems prevail and renal complications arise in adolescence. The mutation of the gene <it>OCRL1 </it>localized at Xq26.1, coding for the enzyme phosphatidylinositol (4,5) bisphosphate 5 phosphatase, PtdIns (4,5)P2, in the trans-Golgi network is responsible for the disease. Both enzymatic and molecular testing are available for confirmation of the diagnosis and for prenatal detection of the disease. The treatment includes: cataract extraction, glaucoma control, physical and speech therapy, use of drugs to address behavioural problems, and correction of the tubular acidosis and the bone disease with the use of bicarbonate, phosphate, potassium and water. Life span rarely exceeds 40 years.</p>http://www.OJRD.com/content/1/1/16
spellingShingle Loi Mario
Lowe syndrome
Orphanet Journal of Rare Diseases
title Lowe syndrome
title_full Lowe syndrome
title_fullStr Lowe syndrome
title_full_unstemmed Lowe syndrome
title_short Lowe syndrome
title_sort lowe syndrome
url http://www.OJRD.com/content/1/1/16
work_keys_str_mv AT loimario lowesyndrome